RxDoctor Payments Data

Brett Sorensen

Podiatrist · Covington, LANPI 1639588361

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,625 of the $2,364 with a category attached, or 68.7%. 8 manufacturers reported payments, led by ALON Medical Technology at 31.3% of the total. Reporting peaked in 2019 at $790 and has fallen 64.5% since, to $280 in 2025. That places this record below the midpoint for podiatrist clinicians in LA, where the typical reported total is $2,398.

$2,364in general payments, 2019–2025

Across 57 payments — averaging $41.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ALON Medical Technology$739
  • Organogenesis Inc.$673
  • Stryker$662
  • Nevro Corp.$118
  • Treace Medical Concepts, Inc.$97
  • Biocomposites Inc$37
  • plus $37 from 2 others

What the payments were for

  • Food & beverage$1,62569%
  • Education$73931%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,364 in reported general payments places this provider in the 45th percentile of 68 podiatrist providers in Louisiana.

See all podiatrist providers in Louisiana

Medicare billing

Part B allowed, 2024
$45,409
Medicare patients
275
Services billed
709

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin158$2,128
Pregabalin74$1,390
Ketoconazole50$924
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen89$596
Doxycycline Hyclate77$519
CiclopiroxCiclopirox Olamine12$359
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav27$223
Ammonium Lactate11$220
Methylprednisolone21$186
Cefdinir12$178
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen38$169
Mupirocin11$99
Meloxicam25$63
Ciprofloxacin Hcl12$55

Paid to pharmacies, not to this prescriber.

Other podiatrist in Covington

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →